Experience

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

September 9, 2024

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Edmond Lay
Partner, San Diego
Ben Beerle
Partner, San Francisco
Leina Verrier
Associate, Santa Monica
Jack Whitaker
Associate, San Diego
Dillon Martinson
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Megan Browdie
Partner, Washington, DC
Nicholas Orr
Associate, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Linh Nguyen
Associate, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kate Walther
Paralegal Specialist, San Diego
John Sellers
Senior Counsel, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.